In 2016, an update on the classification of lymphoid neoplasm was published, and one of the modifications made focussed on B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt’s lymphoma, a term which has now been abandoned. This represented a very difficult disease in the diagnostic routine of pathologists. The new proposed term is high-grade B-cell lymphoma, which includes the double-hit lymphomas. Yet, there was still confusion about the diagnostic criteria. This review discusses the changes in classification, with an emphasis on the double-hit lymphomas. Diffuse large B-cell lymphoma and Burkitt’s lymphoma are also commented on in the text. The diagnosis of double-hit lymphomas is...
The latest version of new WHO classification of lymphoid neoplasms is a comprehensive and distinct o...
The role of cytogenetics in identification of double-hit lymphoma, a subset of a high grade large B-...
Background: Although the WHO classification (2001) requires a great deal of morphologic, immunopheno...
Double/triple hit lymphoma is recognised as a distinct entity within the heterogeneous group of high...
The revised WHO classification moved all aggressive B-cell lymphomas with a MYC translocation and a ...
Background: High-grade B-cell lymphoma (HGBL) with rearrangements of MYC and BCL2 and/or BCL6, calle...
Our understanding of mature aggressive B cell lymphomas has evolved significantly in the last years ...
Burkitt Lymphoma (BL) is listed in the World Health Organization (WHO) classification of lymphoid tu...
Diffuse large B-cell lymphomas (DLBCLs) are aggressive B-cell neoplasms with considerable clinical, ...
Burkitt Lymphoma (BL) is listed in the World Health Organization (WHO) classification of lymphoid tu...
The current classification of lymphoid neoplasms is based on clinical information, morphology, immun...
Diffuse large B-cell lymphoma and Burkitt lymphoma are two distinct lymphoma entities recognized by ...
none6The World Health Organization classification of lymphoid neoplasms updated in 2008 represents a...
In many B-cell lymphomas, chromosomal translocations are biologic and diagnostic hallmarks of diseas...
Objectives: Intermediate-to-large B-cell lymphomas represent a heterogeneous group of aggressive les...
The latest version of new WHO classification of lymphoid neoplasms is a comprehensive and distinct o...
The role of cytogenetics in identification of double-hit lymphoma, a subset of a high grade large B-...
Background: Although the WHO classification (2001) requires a great deal of morphologic, immunopheno...
Double/triple hit lymphoma is recognised as a distinct entity within the heterogeneous group of high...
The revised WHO classification moved all aggressive B-cell lymphomas with a MYC translocation and a ...
Background: High-grade B-cell lymphoma (HGBL) with rearrangements of MYC and BCL2 and/or BCL6, calle...
Our understanding of mature aggressive B cell lymphomas has evolved significantly in the last years ...
Burkitt Lymphoma (BL) is listed in the World Health Organization (WHO) classification of lymphoid tu...
Diffuse large B-cell lymphomas (DLBCLs) are aggressive B-cell neoplasms with considerable clinical, ...
Burkitt Lymphoma (BL) is listed in the World Health Organization (WHO) classification of lymphoid tu...
The current classification of lymphoid neoplasms is based on clinical information, morphology, immun...
Diffuse large B-cell lymphoma and Burkitt lymphoma are two distinct lymphoma entities recognized by ...
none6The World Health Organization classification of lymphoid neoplasms updated in 2008 represents a...
In many B-cell lymphomas, chromosomal translocations are biologic and diagnostic hallmarks of diseas...
Objectives: Intermediate-to-large B-cell lymphomas represent a heterogeneous group of aggressive les...
The latest version of new WHO classification of lymphoid neoplasms is a comprehensive and distinct o...
The role of cytogenetics in identification of double-hit lymphoma, a subset of a high grade large B-...
Background: Although the WHO classification (2001) requires a great deal of morphologic, immunopheno...